Skip to main content

Can carbidopa/levodopa cause high blood pressure?

Medically reviewed by Sally Chao, MD. Last updated on Sep 21, 2023.

Official answer

by drugclasses.com

Carbidopa/levodopa is unlikely to cause high blood pressure (hypertension). It was reported in less than 1% of patients in clinical trials and is not considered a common adverse reaction related to the drug.

However, there have been rare instances of high blood pressure among patients who take both carbidopa/levodopa and tricyclic antidepressants, a class of antidepressant medications that includes Asendin (amoxapine) and Sinequan (doxepin).

Similarly, high blood pressure may occur if patients on carbidopa/levodopa are simultaneously taking or have recently taken Nardil (phenelzine), Parnate (tranylcypromine) or any other nonselective monoamine oxidase inhibitor (MAOI)—another type of antidepressant.

Orthostatic hypotension, or low blood pressure that occurs when standing up, can also be a rare side effect of carbidopa/levodopa. Orthostatic hypotension may occur in patients taking carbidopa/levodopa who also take certain medications to lower their blood pressure (antihypertensive drugs) or selective MAO-B inhibitors such as Azilect (rasagiline) and Eldepryl and Zelapar (selegiline).

Orthostatic hypotension may be indicated by symptoms including:

  • Nausea
  • Sweating
  • Dizziness
  • Fainting

To prevent episodes of orthostatic hypotension, it is helpful to stand up slowly and carefully after lying or sitting down.

References
  1. U.S. Food and Drug Administration (FDA). SINEMET CR (CARBIDOPA-LEVODOPA) SUSTAINED-RELEASE TABLETS. Available at: https://www.accessdata.fda.gov/drugsatfda_docs/label/2008/019856s025lbl.pdf. [Accessed September 27, 2021].
  2. U.S. Food and Drug Administration (FDA). Depression Medicines. Last reviewed November 18, 2019. Available at: https://www.fda.gov/consumers/free-publications-women/depression-medicines. [Accessed September 27, 2021].
  3. U.S. Food and Drug Administration (FDA). RYTARY (carbidopa and levodopa) extended-release capsules, for oral use. Last reviewed January 2015. Available at: https://www.accessdata.fda.gov/drugsatfda_docs/label/2015/203312s000lbl.pdf. [Accessed September 27, 2021].

Read next

How long does it take carbidopa levodopa to work?

The short-acting (immediate-release) formulation of carbidopa/levodopa takes effect within about 20 to 50 minutes. The long-acting (extended-release) formulation starts to work closer to the 50-minute timeframe. Continue reading

How often should carbidopa/levodopa be taken?

The immediate-release (short-acting) form of carbidopa/levodopa is usually taken 3 or 4 times each day, while the extended-release (long-acting) form is typically taken 2 to 4 times each day. Continue reading

How does levodopa help Parkinson's disease?

Levodopa is a central nervous system agent that helps people with Parkinson’s because it is converted into dopamine in the brain. It helps to alleviate the symptoms of the disease by providing a supply of dopamine, which is lacking in people with Parkinson's.

Levodopa works best to help treat the slowness and stiffness or rigidity associated with Parkinson’s disease, and in some cases may treat the tremor as well. It does not slow or reduce the progression of Parkinson’s disease. Continue reading

Related medical questions

Drug information

Related support groups